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ABSTRACT  
Emulgel have emerged as one of the most interesting topical delivery system as it has dual control release system i.e gel and emulsion. Topical 
applications of drug offers many advantages for delivering drug directly to the site of action and deliver the drug for extended period of time at 
effected site. The major objective behind this formulation is to enhance topical delivery of hydrophobic drug (Fusidic acid) by formulating 
Fusidic acid emulgel by using carbopol 934 as gelling agent. In addition light liquid paraffin as oil, span 20 as emulsifier and propylene glycol as 
co-surfactant were selected for the preparation of emulgel. Fusidic acid is steroidal bacteriostatic agent produced from Fusidium coccineum 
fungus belongs to class of steroids but has no corticosteroids effect and which is useful for the treatment of number of infections. Fusidic acid 
binds to protein and ribosomes and inhibits bacterial protein synthesis. The prepared emulgel were evaluated for their physical appearance, pH 
determination, viscosity, spreadability, in-vitro drug release, antimicrobial activity, skin irritation study and stability. All the prepared emulgel 
showed acceptable physical properties. The best formulation E9 shows better drug release when compared to all formulation.  
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INTRODUCTION 
Topical drug administration is simplest and best route for 
restricted drug delivery within a body by route as 
ophthalmic, rectal, vaginal and skin.1 Topical drug delivery is 
defined as localized application of formulation within the 
body through ophthalmic, rectal, nasal, vaginal and skin with 
approach to extend its bioavailability and reduction in side 
effects. Emulgel are the combination of emulsions and gels.2 
Emulsion either of oil in water or water in oil type, which are 
gelled by mixing with a gelling agents.3 Emulgel acts as dual 
control of drug release from the formulation, due to the 
presence of both aqueous and non-aqueous phase.4 Emulgel 
are widely used for delivery of drug through the skin. Its 
function in dermatology is realized mainly due to the 
advantages such as easy incorporation of hydrophobic 
drugs, thixotrophy, greaseless, easily spreadable, easy 
removable, emollient, non-staining, water soluble, 
biocompatibility with greater shelf life and pleasant 
appearance.5 
Gel formulations typically show higher drug release than 
ointment and creams. In spite of many advantages of 
emulsions and gels a major disadvantages is their inability to 
deliver hydrophobic drug and instability during storage. 
Such type of problems are overcome by using the emulsion 
based approach that is emulgel preparation and thereby 
hydrophobic drug and successfully incorporated and have 
unique property of gels.6 Fusidic acid is steroidal 
bacteriostatic agents produced from Fusidium coccineum 
fungus belongs to class of steroids but has no corticosteroids 
effects. It is used to treat atopic dermatitis, cellulitis, contact 
dermatitis and prurigo. It is BCS class II drug whose 
bioavailability is rate limited.7 It binds to protein and 
ribosomes and inhibit further bacterial protein synthesis. 
The action of FA is largely bacteriostatic but at high 
concentration the effect may be bactericidial.8 
MATERIALS AND METHODS 
Materials: 
Fusidic acid was received as gift sample from Bharat 
Parenteral Pvt. Ltd (Vadodara, India). Carbopol 934 was 
obtained from Chiti-chem Corporation, Light liquid paraffin 
was obtained from Qualikems fine chem. Pvt. Ltd. Propylene 
Glycol was obtained from Suvidhinath Laboratories, and 
Span 20 was obtained from Qualikems fine Chem. Pvt. Ltd. 
Peppermint oil was obtained from Aaturinstru chem. 
Triethanolamine was obtained from Chemdyes Corporation 
and methyl paraben was obtained from Oxford lab.
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 Preparation and evaluation of all batches (E1-E9) of emulgel 
Table 1: Design summary 
 
Factor 
 
Name 
Coded level Actual level 
Low Medium High Low Medium High 
A Carbopol 934 -1 0 +1 1.75 2 2.25 
B Light liquid paraffin -1 0 +1 5 6 7 
 
Table 2: Formulation table of (E1-E9) batches of emulgel 
Ingredients (%w/w) E1 E2 E3 E4 E5 E6 E7 E8 E9 
Fusidic acid  1 1 1 1 1 1 1 1 1 
Carbopol 934 2 2.25 1.75 1.75 2.25 2 1.75 2.25 2 
Liquid paraffin 6 7 5 6 5 5 7 6 7 
Propylene glycol 5 5 5 5 5 5 5 5 5 
Span 20 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
Peppermint oil 2 2 2 2 2 2 2 2 2 
Methyl paraben 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
Triethanolamine  q.s q.s q.s q.s q.s q.s q.s q.s q.s 
Water  q.s q.s q.s q.s q.s q.s q.s q.s q.s 
 
 
The oil phase of emulsion was prepared by dissolving span 
20 in light liquid paraffin and peppermint oil, also Fusidic 
acid was mixed in oil phase. While the aqueous phase of 
emulsion was prepared by dissolving in span 20 in distilled 
water. Methyl paraben were dissolved in propylene glycol 
and mixed with aqueous phase. Both the oily and aqueous 
phases were separately heated at 70°C-80°C, then the oily 
phase was added to the aqueous phase with continuous 
stirring until it was cooled to room temperature. The 
emulsion was obtained, which is stored in well closed air 
tight container.9 
Preparation of gel:  
The quantity of carbopol 934 were weighed and mixed 
homogenously with distilled water 65-70°C by using 
magnetic stirrer, stirring speed is 1000±200 RPM for 10 min 
to form smooth dispersion. The preparation is allowed to 
stand, permitting entrapped air to separate. Then the pH was 
adjusted to 6-6.5 by using triethanolamine.10 
Preparation of emulgel: 
Emulsion was incorporated into gel base in 1:1 ratio under 
continuous mixing using mechanical stirrer at 5000-6000 
RPM for 10-20 minutes to obtained emulgel. 
Preformulation study:  
Organoleptic characterization of drug: 
Melting point: Melting point of the drug was found to be 
190°C-195°C by using capillary tube method. The readings 
were taken in triplicate and average was taken. The 
reference melting point is in the average 192.5°C. 
Solubility: The solubility of Fusidic acid in different solvent 
was determined by using shake flask method. The result 
obtained was noted below in table 3. 
 
Table 3: Solubility of Fusidic acid in different solvent 
Experiment Parameter Observation 
 
Solubility (mg/ml) 
Solubility in distilled water (mg/ml) 0.091±0.01 
Solubility in phosphate buffer pH 5.5 (mg/ml) 0.403±0.04 
Each observation value are expressed as mean ±S.D. n=3 
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FTIR Spectroscopy: 
FTIR spectrum (Shown in Figure 1) of drug sample showed 
all the characteristics IR peaks as reported in indicating the 
presence of Fusidic acid shown in table 4. 
UV spectroscopy: 
Maximum absorbance of Fusidic acid in phosphate buffer pH 
5.5. The λmax of Fusidic acid in methanol was found to be at 
204nm this is characteristics property of Fusidic acid in its 
pure form, hence it can be confirmed that obtained sample 
was authentic.  
Calibration curve of Fusidic acid in phosphate buffer pH 
5.5 
The calibration curve of Fusidic acid was prepared in 
phosphate buffer pH 5.5. table 4 shows the absorbance at 
λmax 204nm for different concentration of Fusidic acid and 
figure 1 shows calibration curve. 
 
Figure 1: Calibration curve of Fusidic acid in phosphate 
buffer pH 5.5 
Table 4: Calibration curve data of Fusidic acid in 
phosphate buffer pH 5.5 
Concentration (µg/ml) Absorbance ± SD 
5 0.0802±0.06 
10 0.1727±0.07 
15 0.2908±0.06 
20 0.4030±0.06 
25 0.5077±0.03 
30 0.6094±0.05 
 
Evaluation of emulgel containing emulsion (of optimized 
batch E9) of Fusidic acid. 
1. Physical examination: 
The colour of formulation was checked against white and 
black background. The consistency of emulgel was checked 
by applying on skin. The odor of emulgel was checked by 
mixing it in water and by smelling it.11 
2. pH: 
1% solution of emulgel were prepared and subjected to 
measure pH by digital pH meter. 
3. Drug-excipient compatibility study: 
FTIR spectra of Fusidic acid and other excipients like 
carbopol 934 was compared with spectra of prepared 
emulgel formulation.12 
4. Viscosity: 
The rheological property of emulgel sample was determined 
by using Brookfield viscometer. 
5. Spreadability: 
A lower glass slide was fixed on this block. An excess of 
prepared emulgel (1gm) was placed on ground slide. 
Emulgel formulation was then sandwiched between the slide 
and another glass slide having the dimension of fixed ground 
slide and provided by hook. Weight of 100gm was placed on 
top of two slides for 5 min to expel air and to provide 
uniform film of gel between the slide. Excess of emulgel was 
scrapped off from the edges. Upper slide was then subjected 
to pull 20g weight with the help of string attached to hook 
and the time required by upper slide to cover distance. 
Shorter interval indicated better spreadability. 
Spreadability (S) was calculated as follow: 
S=M.L/T 
6. Drug content: 
Drug content in emulgel was measured by dissolving 1gm of 
emulgel in 100ml of solvent (a mixture of ethanol). After 
filter the solution to obtain a clear solution and subjected to 
spectrophotometric analysis after suitable dilution. 
7. In-vitro drug diffusion study: 
Release of Fusidic acid from emulgel formulation was 
measured through dialysis membrane by using franz 
diffusion cell. Dialysis membrane was soaked in diffusion 
media for overnight and then placed on support screen of 
diffusion cell assembly. Phosphate buffer at pH 5.5 was used 
as the receptor medium and 1g of gel was placed on the 
donor side. At predetermined time interval, 2ml of sample 
was withdrawn from the receptor compartment and 
replaced with same volume of phosphate buffer at pH 5.5. 
The aliquots were analyzed by UV spectrophotometer at 
204nm. 
8. Skin irritation study:  
All the procedure related with animal experiment were 
carried out in accordance with committee for purpose of 
experiments on animal guidelines (CPSCEA). The study was 
reviewed and approved by Institutional Ethics Committee 
(protocol No. OGECT/PPDC/IAEC/2019/18/2). Adult New 
Zealand rabbit was kept in controlled condition, temperature 
26-28°C relative humidity 60-70°C and 12/12 hour light-
dark cycle and was provided with standard pellet diet and 
water. Emulgel with drug was applied on one side three test 
was applied to the animal. First emulgel was removed after 
three minutes no serious reaction. Second emulgel applied 
and removed after 1hour no observation a third emulgel was 
applied and removed after 4hours and response was graded 
then animal was observed for 14days if corrosive effect 
observed the test was immediately terminated.13, 14 
9. Stability study:  
Emulgel was packed in aluminium collapsible tubes (5gm) 
and subjected to stability study at 5°C, 25°C/60% RH, 
30°C/65%RH for 1 month. Samples are withdrawn at each 
10days as per ICH guidelines and analyzed for their physical 
appearance, pH, drug content, drug release profile etc.15 
RESULT AND DISCUSSION 
The λmax value of Fusidic acid was found to be 204nm in 
phosphate buffer pH 5.5 by using UV spectrophotometer. 
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Figure 2: UV spectrum of Fusidic acid in phosphate buffer pH 5.5 
The IR of Fusidic acid (figure 3) showed the presence of functional group which are present in Fusidic acid (figure) so it indicate 
Fusidic acid is in pure form. 
 
Figure 3: FTIR spectrum of Fusidic acid 
Sr.no Functional group 
(stretching) 
wavenumber(cm-1) 
Fusidic acid 
1 OH 3443.11 
2 C-H(Aliphatic) 2869.26 
3 C-H 2949.28 
4 C=O(Ester) 1747.38 
5 C=C 1563.92 
6 C-O 1149.08 
Table 5: FTIR spectrum of Fusidic acid 
 
The observed emulsion was found to be oil in water type. 
The pH of all batches (E1-E9) was found to be in the range of 
5.1±0.05 to 5.7±0.15. The viscosity of all batches (E1-E9) was 
found to be in range of 8791±2.25 cps to 9928 ±1.51 cps. The 
spreadability of all batches (E1-E9) was found to be range of 
10.88±0.12 to 17.25±0.15. The % Drug Content of all batches 
(E1-E9) was found to be 96.6±0.1 to 99.86±0.03.  
 
Data analysis of formulations: 
A 32 full factorial design was selected and the 2 factors were 
evaluated at 3 levels. The amount of carbopol 934 (A) and 
light liquid paraffin (B) were selected as independent 
variables and the dependent variables were % Drug release 
and viscosity. The data obtained was treated using stat-Ease 
Design Expert software. The data clearly indicates that 
%drug release and viscosity were strongly dependent on the 
selected independent variables. 
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ANOVA for Quadratic model:  
 
Figure 4: Contour plot and Response 3D surface plot of carbopol 934 and light liquid paraffin for %drug release 
 
Figure 5: Contour plot and Response 3D surface plot of carbopol 934 and light liquid paraffin for viscosity (cps) 
 
The amount of %drug release from (E1-E2) batches of 
emulgel varied from 85% to 95.05%. from the p-value 
0.0500 it can be concluded that carbopol 934 and light liquid 
paraffin have prominent effect (p<0.05) on %drug release. 
The amount of viscosity from the (E1-E9) batches of 
emulsion varied from 8791 to 9925 cps. From the p-value 
0.0500 it can be concluded that carbopol 934 and light liquid 
paraffin have prominent effect (P<0.05) on viscosity. 
Evaluation of emulgel containing optimized (batch E9) 
of Fusidic acid: 
1. Physical examination:  
The prepared emulgel containing (optimized batch E9) of 
Fusidic acid was inspected visually for their colour white, 
consistency good and odour aromatic. 
2. Determination of pH:  
pH of prepared emulgel was found to be 5.1±0.05 to 
5.7±0.17 which compliance with skin pH range 4.5 to 6.5. 
3. Drug excipients compatibility study: 
An FTIR spectrum of formulation shows significant peaks of 
fusidic acid indicating no interaction between fusidic acid 
and excipients (figure 6) 
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Figure 6: FTIR of Fusidic acid and Fusidic acid and carbopol 934 
Table 6: FTIR of Fusidic acid and carbopol 934 
Sr.no Functional group 
(stretching) 
Wavenumber (cm-1) 
Fusidic acid API+ carbopol 
1 OH 3443.11 3443.17 
2 C-H(Aliphatic) 2869.26 2870.32 
3 C-H 2949.28 2948.25 
4 C=O(Ester) 1747.38 1746.99 
5 C=C 1563.92 1564.07 
6 C-O 1149.08 1150.08 
 
 
4. Viscosity:  
Viscosity was found to 9925 cps. Viscosity was increased 
with increase in emulsifier concentration. 
5. Spreadability: 
The spreadability of emulgel was found to 17.25±0.17 
gm.cm/sec. Spreadability of emulgel was increased due to 
presence of propylene glycol as humectants. 
6. Drug Content: 
%Drug content of emulgel formulation was found to be 
99.86±0.03% which is within the pharmacopieal limits. 
7. In-vitro drug diffusion study:  
At the end of 8 hours the total amount of drug release from 
the formulation was found to 95.25 so it showed better 
%CADD from emulgel formulation (Table and Figure)
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Table 7: % CADD of emulgel 
Time (hrs) %CADD Average ± SD 
0.5 4.7 
1 10.1 
2 22.1 
3 31.4 
4 42.3 
5 48.5 
6 60.4 
7 74.3 
8 95.25 
 
 
Figure 7: In-vitro drug diffusion study of emulgel
 
8. Skin Irritation study: 
No allergic symptoms like inflammation, redness, irritation appeared on rats upto 24 hours and for 14 days. 
Table 8: Stability test of emulgel 
 
  PARAMETERS 
Optimized Fusidic acid loaded emulgel 
Room temperature 
0 Day 10 Day 20 Day 30 Day 
Colour White White White White 
Odour Odourless Odourless Odourless Odourless 
pH 5.28 5.22 5.12 5 
Spreadability 12.64 12.52 12.42 12.22 
Viscosity (CPS) 9928 9919 9912 9905 
% Drug content 99.86 99.23 98.56 97.55 
 
Stability study of prepared emulgel formulation was 
performed as per ICH guidelines. It can observe that the 
emulgel formulation showed no major alteration in relation 
to the appearance, pH, drug content and in-vitro drug release 
study. From (table) it can be concluded that the prepared 
emulgel formulation was found to be stable upon storage for 
1 month. 
CONCLUSION 
In the coming years topical drug delivery will be used 
extensively to impart better patient compliance. Since 
emulgel is helpful in enhancing spreadability, viscosity, this 
novel drug delivery become popular. Furthermore, they will 
become a solution for loading hydrophobic drugs in water 
soluble gel bases for long term stability. Similar in the study, 
topical emulgel of Fusidic acid was formulated and subjected 
to physiochemical studies i.e appearance, rheological studies, 
spreadability and in vitro drug release. In vitro drug release 
of the tests formulation was performed to determine drug 
release from emulgel rate and duration of drug release. From 
in vitro study formulation shows maximum release 95.25% 
in 8 hours. Prepared emulgel containing Fusidic acid showed 
significant result of anti-inflammatory activity. So emulgel 
containing Fusidic acid can be used as an steroidal 
bacteriostatic agents for topical drug delivery.  
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